Synopsis:
In this article, we evaluated the prognostic value of FLT3-ITD and CEBPA mutations in ALL. We did not detect any relationship between FLT3-ITD and CEBPA mutations as prognostic factors. However, FLT3-ITD mutation may affect the response to chemotherapy.